{"id":"NCT00669617","sponsor":"Novartis","briefTitle":"Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)","officialTitle":"A Phase III, Randomized, Double-blind, Triple-dummy, Placebo Controlled, Multicenter, 5-period, Single-dose Complete Block Crossover Study to Determine the Onset of Action of Indacaterol (150 and 300 μg) in Patients With Moderate to Severe COPD Using Salbutamol (200 μg) and Salmeterol/Fluticasone (50/500 μg) as Active Controls","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-04","primaryCompletion":"2008-08","completion":"2008-08","firstPosted":"2008-04-30","resultsPosted":"2011-08-17","lastUpdate":"2011-09-12"},"enrollment":89,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease"],"interventions":[{"type":"DRUG","name":"Indacaterol","otherNames":["Arcapta","Neohaler"]},{"type":"DRUG","name":"Salmeterol/fluticasone (50/500 μg)","otherNames":[]},{"type":"DRUG","name":"Salbutamol (200 µg)","otherNames":[]},{"type":"DRUG","name":"Placebo to Indacaterol","otherNames":[]},{"type":"DRUG","name":"Placebo to Salmeterol/fluticasone","otherNames":[]},{"type":"DRUG","name":"Placebo to salbutamol","otherNames":[]}],"arms":[{"label":"Ind 150μg, Salm/flut, Ind 300μg, Placebo, Salbut","type":"EXPERIMENTAL"},{"label":"Ind 300μg, Ind 150μg, Salbut, Salm/flut, Placebo","type":"EXPERIMENTAL"},{"label":"Salm/flut, Placebo, Ind 150μg, Salbut, Ind 300μg","type":"EXPERIMENTAL"},{"label":"Salbut, Ind 300μg, Placebo, Ind 150μg, Salm/flut","type":"EXPERIMENTAL"},{"label":"Placebo, Salbut, Salm/flut , Ind 300μg, Ind 150μg","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the onset of action of indacaterol (150 and 300 µg) as compared to placebo, salbutamol 200 µg and salmeterol/fluticasone 50/500 µg","primaryOutcome":{"measure":"Forced Expiratory Volume in 1 Second (FEV1) at 5 Minutes Post-dose","timeFrame":"Five Minutes Post Dose","effectByArm":[{"arm":"Indacaterol 150 µg","deltaMin":1.48,"sd":0.014},{"arm":"Indacaterol 300 µg","deltaMin":1.5,"sd":0.014},{"arm":"Placebo","deltaMin":1.38,"sd":0.014},{"arm":"Salmeterol/Fluticasone","deltaMin":1.43,"sd":0.014},{"arm":"Salbutamol","deltaMin":1.47,"sd":0.014}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":15},"locations":{"siteCount":17,"countries":["United States","Belgium","Germany","Hungary"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":86},"commonTop":[]}}